Evidence map›Paper›PMID 40361511›Full record

ArticleCancers2025

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Elena Crisà, Daniela Cilloni, Marta Riva, Enrico Balleari, Daniela Barraco, Beatrice Manghisi, Lorenza Borin, Michela Calmasini, Anna Calvisi, Isabella Capodanno and 28 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Elena CrisàCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0003-1912-0574
Daniela CilloniA.O. Ordine Mauriziano di Torino, Department of Clinical and Biological Sciences, University of Turin, 10128 Turin, Italy.ORCID 0000-0001-6346-4791
Marta RivaHematology, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
Enrico BalleariIRCCS Policlinico Ospedale San Martino, 16132 Genoa, Italy.ORCID 0009-0009-2957-6170
Daniela BarracoDipartimento di Ematologia, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, 21100 Varese, Italy.
Beatrice ManghisiHematology, Ospedale San Gerardo, 20900 Monza, Italy.
Lorenza BorinHematology, Ospedale San Gerardo, 20900 Monza, Italy.
Michela CalmasiniAssociazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, 20162 Milan, Italy.
Anna CalvisiSC Ematologia, CTMO e Laboratorio Specialistico, Ospedale S. Francesco, 08100 Nuoro, Italy.
Isabella CapodannoSOC Ematologia Azienda USL-IRCSS di Reggio Emilia, 42122 Reggio Emilia, Italy.
Matteo Giovanni Della PortaCancer Center, IRCCS Humanitas Research Hospital, Humanitas University, 20089 Rozzano, Italy.
Elisa DiralUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-4994-7719
Bruno FattizzoDepartment of Oncology and Onco-Hematology, University of Milan, 20122 Milan, Italy.ORCID 0000-0003-0857-8379
Susanna FenuHaematology Department, San Giovanni-Addolorata Hospital, 00184 Rome, Italy.
Stefania PaoliniIstituto di Ematologia Seràgnoli, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
Carlo FinelliIstituto di Ematologia Seràgnoli, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-9372-1197
Claudio FozzaDepartment of Clinical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy.
Chiara FrairiaHematology, Hospital Città della Salute e della Scienza, 10126 Turin, Italy.
Valentina GiaiHematology, Hospital Città della Salute e della Scienza, 10126 Turin, Italy.ORCID 0009-0009-4238-1300
Mauro TurriniDivision of Hematology, Ospedale Valduce, 22100 Como, Italy.ORCID 0000-0001-5299-8456
Maria Antonia IsoniIstituto di Ematologia, Università di Sassari, 07100 Sassari, Italy.
Federico ItriDivision of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.
Luca MaurilloHematology Division, UOSD Malattie Mieloproliferative, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-7297-4988
Alfredo MolteniHematology, ASST Cremona, 26100 Cremona, Italy.
Giuseppe Alberto PalumboUnità Operativa di Ematologia con TMO AOU "Policlinico-San Marco", Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, 95123 Catania, Italy.ORCID 0000-0003-1859-6319
Anna Maria PelizzariDepartment of Hematology, Spedali Civili di Brescia, 25123 Brescia, Italy.
Federica PiloHematology and Transplant Center, Ospedale Oncologico di Riferimento Regionale "Armando Businco", Azienda Ospedaliera Brotzu, 09121 Cagliari, Italy.
Antonella PoloniHematology, Università Politecnica Marche, AOU Marche, 601221 Ancona, Italy.
Costanza BosiEmatologia e Centro Trapianti, Ospedale Guglielmo da Saliceto, 29121 Piacenza, Italy.
Grazia SanpaoloUOC Ematologia Fondazione Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Rosaria SancettaHematology/Bone Marrow Transplantation Unit, Ospedale dell'Angelo and Ospedale SS. Giovanni e Paolo, 30174 Venezia, Italy.
Cristina AmatoMDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, 50134 Florence, Italy.
Valeria SantiniMDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-5439-2172
Maria Teresa VosoDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-6164-4761
Sam SalekSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.
Tatyana IonovaSt. Petersburg State University Hospital, St. Petersburg 190103, Russia.
Annamaria NosariAssociazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, 20162 Milan, Italy.
Esther Natalie OlivaHematology Department, London North West University Healthcare NHS Trust, London HA1 3UJ, UK.ORCID 0000-0001-9238-5734

Funding

AIPASIM N/A
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe aim of this study was to assess the unmet needs of myelodysplastic neoplasm (MDS) patients and their caregivers, focusing on how these needs impact quality of life (QoL) and daily functioning. MDS predominantly affects older adults. It is often complicated by severe red blood cell transfusion-dependent anemia and may require frequent hospital visits, conferring a substantial burden on patients and caregivers.

methodsA national survey was conducted between June 2022 and May 2023 in 46 hematology centers across Italy, involving 259 patients and 105 caregivers. The survey included validated QoL tools (QOL-E and HM-PRO) to measure the impact of disease and treatments on health-related QoL and symptoms.

resultsOf the 259 patients surveyed, 42% were transfusion-dependent, with 45% reporting distress related to hospital travel, which was significantly associated with lower QoL scores (QOL-E physical score 50.0 vs. 62.5,

conclusionsThis study identified substantial unmet needs for MDS patients, particularly in addressing the heavy burden of transfusions and hospital visits. Both patients and caregivers experienced significant impact on daily life and on QoL, highlighting the urgent need for treatments that reduce hospital dependency, improve patient outcomes, and alleviate the caregiver burden.

Indexed as

caregiversmyelodysplastic neoplasmsquality of lifetransfusion dependencyunmet needs

Identifiers

PMID40361511
PMCPMC12072108

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.